Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
Estanislao
Nistal Villán
Publications dans lesquelles il/elle collabore avec Estanislao Nistal Villán (17)
2023
-
Biología celular del cáncer
Biología celular biomédica (Elsevier), pp. 375-407
-
Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution
Frontiers in Immunology, Vol. 14
2022
-
Broad virus inactivation using inorganic micro/nano-particulate materials
Materials Today Bio, Vol. 13
-
Targeting Signaling Pathway Downstream of RIG-I/MAVS in the CNS Stimulates Production of Endogenous Type I IFN and Suppresses EAE
International Journal of Molecular Sciences, Vol. 23, Núm. 19
2021
-
Linking the Expression of Therapeutic Genes to Unfolded Protein Response: A New Option for Anti-Hepatitis B Virus Gene Therapy
Human Gene Therapy, Vol. 32, Núm. 7-8, pp. 341-348
2020
-
Repurposing the yellow fever vaccine for intratumoral immunotherapy
EMBO Molecular Medicine, Vol. 12, Núm. 1
2018
-
TMEM173 Alternative Spliced Isoforms Modulate Viral Replication through the STING Pathway
ImmunoHorizons, Vol. 2, Núm. 11, pp. 363-376
-
miR-146a targets c-met and abolishes colorectal cancer liver metastasis
Cancer Letters, Vol. 414, pp. 257-267
2016
-
A versatile vector for in vivo monitoring of type I interferon induction and signaling
PLoS ONE, Vol. 11, Núm. 3
-
Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function
OncoImmunology, Vol. 5, Núm. 8
-
Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense
Nature Immunology, Vol. 17, Núm. 9, pp. 1037-1045
2015
-
A RIG-I 2CARD-MAVS200 Chimeric Protein Reconstitutes IFN-β Induction and Antiviral Response in Models Deficient in Type i IFN Response
Journal of Innate Immunity, Vol. 7, pp. 466-481
-
Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
Molecular Cancer, Vol. 14, Núm. 1
-
The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties
Cancer Letters, Vol. 356, Núm. 2, pp. 899-909
2014
-
New syngeneic inflammatory-related lung cancer metastatic model harboring double KRAS/WWOX alterations
International Journal of Cancer, Vol. 135, Núm. 11, pp. 2516-2527
2013
-
T cell costimulation with anti-CD137 monoclonal antibodies is mediated by K63-polyubiquitin-dependent signals from endosomes
Journal of Immunology, Vol. 190, Núm. 12, pp. 6694-6706
2012
-
Structure and dynamics of the second CARD of human RIG-I provide mechanistic insights into regulation of RIG-I activation
Structure, Vol. 20, Núm. 12, pp. 2048-2061